Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: J Invest Dermatol. 2012 Mar 8;132(6):1689–1697. doi: 10.1038/jid.2012.36

Figure 3.

Figure 3

Figure 3

Kaplan-Meier survival curves for melanoma patients using combination of LINE-1 and AIM1 methylation status in PEAT. M=hypermethylated, U=hypomethylated. A: OS of patients with LINE-1 hypomethylation and/or AIM1 hypermethylation versus LINE-1 hypermethylation and AIM1 hypomethylation. B: DFS of stage I-II melanoma patients with LINE-1 hypomethylation and/or AIM1 hypermethylation vs. LINE-1 hypermethylation and AIM1 hypomethylation.

HHS Vulnerability Disclosure